Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 210105
Company: AMNEAL PHARMS NY
Company: AMNEAL PHARMS NY
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
BEXAROTENE | BEXAROTENE | 75MG | CAPSULE;ORAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
09/04/2018 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
BEXAROTENE
CAPSULE;ORAL; 75MG
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
BEXAROTENE | BEXAROTENE | 75MG | CAPSULE;ORAL | Prescription | No | AB | 210105 | AMNEAL PHARMS NY |
BEXAROTENE | BEXAROTENE | 75MG | CAPSULE;ORAL | Prescription | No | AB | 209861 | ANI PHARMS |
BEXAROTENE | BEXAROTENE | 75MG | CAPSULE;ORAL | Prescription | No | AB | 208628 | ASCENT PHARMS INC |
BEXAROTENE | BEXAROTENE | 75MG | CAPSULE;ORAL | Prescription | No | AB | 203174 | BIONPHARMA |
BEXAROTENE | BEXAROTENE | 75MG | CAPSULE;ORAL | Prescription | No | AB | 203663 | HIKMA |
BEXAROTENE | BEXAROTENE | 75MG | CAPSULE;ORAL | Prescription | No | AB | 209931 | TEVA PHARMS USA |
BEXAROTENE | BEXAROTENE | 75MG | CAPSULE;ORAL | Prescription | No | AB | 209886 | UPSHER SMITH LABS |
TARGRETIN | BEXAROTENE | 75MG | CAPSULE;ORAL | Prescription | Yes | AB | 021055 | VALEANT LUXEMBOURG |